Page last updated: 2024-10-31

mitoxantrone and Cancer of Nose

mitoxantrone has been researched along with Cancer of Nose in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, HH1
Qian, LT1
Pan, HF1
Yang, L1
Zhang, HY1
Wang, ZH1
Ma, J1
Zhao, YF1
Gao, J1
Wu, AD1
Kouzaki, H1
Kitanishi, T1
Kitano, H1
Suzuki, M1

Trials

1 trial available for mitoxantrone and Cancer of Nose

ArticleYear
Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad

2010

Other Studies

1 other study available for mitoxantrone and Cancer of Nose

ArticleYear
Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
    Auris, nasus, larynx, 2004, Volume: 31, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cycloph

2004